The role of chronic inflammation in polycystic ovarian syndrome—a systematic review and meta-analysis

S Aboeldalyl, C James, E Seyam, EM Ibrahim… - International journal of …, 2021 - mdpi.com
Although the current literature associates polycystic ovarian syndrome (PCOS) with chronic
inflammation, the evidence for this link remains inconclusive and its causal nature remains …

Polycystic ovary syndrome and aging: Health implications after menopause

N Helvaci, BO Yildiz - Maturitas, 2020 - Elsevier
Polycystic ovary syndrome (PCOS) is a common endocrine disorder with heterogenous
clinical manifestations. The evidence indicates that PCOS is associated with long-term …

Shaoyao-gancao decoction ameliorates the inflammation state in polycystic ovary syndrome rats via remodeling gut microbiota and suppressing the TLR4/NF-κB …

Z Chang, G Deng, Y Shao, D Xu, Y Zhao… - Frontiers in …, 2021 - frontiersin.org
Background: Emerging evidence suggests that gut microbiota plays a vital role in the
occurrence of multiple endocrine disorders including polycystic ovary syndrome (PCOS) …

Oxidative stress is increased in combined oral contraceptives users and is positively associated with high-sensitivity C-reactive protein

S Cauci, S Xodo, C Buligan, C Colaninno, M Barbina… - Molecules, 2021 - mdpi.com
Information concerning the mechanisms underlying oxidative stress and low-grade
inflammation in young healthy women predisposing eventually to future diseases is scarce …

Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte …

SD Yousuf, MA Ganie, U Urwat, SM Andrabi… - BMC women's …, 2023 - Springer
Background Polycystic ovary syndrome (PCOS) presents clinical symptoms of menstrual
abnormalities, excessive hair growth (hirsutism), scalp hair loss, acne and infertility …

Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study

D Glintborg, KH Rubin, M Nybo… - Endocrine …, 2019 - ec.bioscientifica.com
Aim To investigate risk of thyroid disease in Danish women with PCOS. Design National
register-based study on women with PCOS in Denmark. 18,476 women had a diagnosis of …

Metabolic effects of hormonal contraception in women with and without polycystic ovary syndrome

ME Mosorin - 2024 - oulurepo.oulu.fi
Hormonal contraceptives are widely used for birth control and for the treatment of symptoms
related to polycystic ovary syndrome (PCOS), such as menstrual irregularities, hirsutism and …

Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome

J Yu, Y Zhou, J Ding, D Zhang, C Yu… - Frontiers in …, 2023 - frontiersin.org
Background Polycystic ovary syndrome (PCOS) is a kind of endocrine and metabolic
disorder, disturbing the females of reproductive age. Here, we aimed to investigate the …

Interleukin-22/Interleukin-22 binding protein axis and oral contraceptive use in polycystic ovary syndrome

S Aksun, E Ersal, O Portakal, BO Yildiz - Endocrine, 2023 - Springer
Purpose Polycystic ovary syndrome (PCOS) is associated with alterations in gut microbiota.
The cytokine interleukin-22 (IL-22) is produced by immune cells and closely linked to gut …

Combined oral contraceptive use and obesity in women with polycystic ovary syndrome. A meta-analysis of randomized clinical trials

SF de Medeiros, JMS Junior, MAS de Medeiros… - Archives of Gynecology …, 2024 - Springer
Background Polycystic ovary syndrome (PCOS) is a heterogenous endocrine condition and
combined oral contraceptives (COCs) have been demonstrated to be the first-line treatment …